SBFM Q1 2019 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$206-99.8% YoY

Gross Profit

$34,86216923.3% margin

Operating Income

-$122,209-59324.8% margin

Net Income

-$202,542-98321.4% margin

EPS (Diluted)

$-18412.91

QoQ Revenue Growth

-99.8%

Cash Flow

Operating Cash Flow

-$233,959

Free Cash Flow

-$233,959

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1M

Total Liabilities

$1M

Stockholders' Equity

-$211,772

Cash & Equivalents

$95,129

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$206	$91,168	-99.8%
Gross Profit	$34,862	-$9,651	+461.2%
Operating Income	-$122,209	-$166,697	+26.7%
Net Income	-$202,542	-$265,636	+23.8%